1. Home
  2. AIO vs EMBC Comparison

AIO vs EMBC Comparison

Compare AIO & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

AIO

Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

HOLD

Current Price

$22.45

Market Cap

805.3M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$12.37

Market Cap

719.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIO
EMBC
Founded
2019
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
805.3M
719.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AIO
EMBC
Price
$22.45
$12.37
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
141.5K
697.1K
Earning Date
01-01-0001
02-05-2026
Dividend Yield
9.05%
4.84%
EPS Growth
N/A
20.90
EPS
N/A
1.62
Revenue
N/A
$1,080,400,000.00
Revenue This Year
N/A
$2.18
Revenue Next Year
N/A
$0.09
P/E Ratio
N/A
$7.65
Revenue Growth
N/A
N/A
52 Week Low
$15.09
$9.20
52 Week High
$20.25
$21.23

Technical Indicators

Market Signals
Indicator
AIO
EMBC
Relative Strength Index (RSI) 47.09 52.71
Support Level $21.76 $11.38
Resistance Level $22.33 $12.15
Average True Range (ATR) 0.41 0.40
MACD -0.01 0.12
Stochastic Oscillator 43.48 78.23

Price Performance

Historical Comparison
AIO
EMBC

About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest

Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: